AB1129
Anti-Rotavirus Antibody
Chemicon®, from goat
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
About This Item
Código UNSPSC:
12352203
eCl@ss:
32160702
NACRES:
NA.41
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Productos recomendados
origen biológico
goat
Nivel de calidad
forma del anticuerpo
purified immunoglobulin
clon
polyclonal
reactividad de especies
human
fabricante / nombre comercial
Chemicon®
técnicas
ELISA: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
western blot: suitable
Condiciones de envío
wet ice
Especificidad
Rotavirus (ICP′s and late structural virion antigens). Greater than 90% reactive with human rotaviruses. Non reactive with HEp-2 cells and WI-38 cells.
Inmunógeno
Bovine (Nebraska Calf Diarrhea Virus)
Aplicación
Indirect immunofluorescence: 1:250
ELISA
Immunoblotting; unboiled samples in 1mM DTT and 2% SDS only.
Immunohistochemistry
Final working dilutions must be determined by end user.
ELISA
Immunoblotting; unboiled samples in 1mM DTT and 2% SDS only.
Immunohistochemistry
Final working dilutions must be determined by end user.
Research Category
Infectious Diseases
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
Infectious Diseases - Viral
This Anti-Rotavirus Antibody is validated for use in ELISA, IF, WB, IH for the detection of Rotavirus.
Forma física
Format: Purified
Purified immunoglobulin. In PBS (0.01 M, pH 7.2) with 0.1% sodium azide
Almacenamiento y estabilidad
Maintain at -20°C in undiluted aliquots for up to 12 months. Avoid repeated freeze/thaw cycles.
Información legal
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Cláusula de descargo de responsabilidad
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Código de clase de almacenamiento
12 - Non Combustible Liquids
Clase de riesgo para el agua (WGK)
WGK 2
Punto de inflamabilidad (°F)
Not applicable
Punto de inflamabilidad (°C)
Not applicable
Certificados de análisis (COA)
Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Christina McCowan et al.
PloS one, 13(9), e0203853-e0203853 (2018-09-12)
Cases of vomiting and diarrhoea were reported in racing pigeons in Western Australia in May, 2016. Morbidity and mortality rates were high. Similar clinical disease was seen in Victoria in December and by early 2017 had been reported in all
Mai Kishimoto et al.
Journal of virology, 97(1), e0145522-e0145522 (2023-01-13)
Rotavirus A (RVA) causes diarrheal disease in humans and various animals. Recent studies have identified bat and rodent RVAs with evidence of zoonotic transmission and genome reassortment. However, the virological properties of bat and rodent RVAs with currently identified genotypes
Na Yin et al.
World journal of gastroenterology, 24(45), 5109-5119 (2018-12-21)
To establish a rotavirus (RV)-induced diarrhea model using RV SA11 in neonatal rhesus monkeys for the study of the pathogenic and immune mechanisms of RV infection and evaluation of candidate vaccines. Neonatal rhesus monkeys with an average age of 15-20
Na Yin et al.
Human vaccines & immunotherapeutics, 17(12), 5656-5665 (2022-02-27)
Live-attenuated rotavirus vaccine has shown low protection in underdeveloped or developing countries. However, the inactivated rotavirus vaccine may have the potential to overcome some of these challenges. In the present study, the immunogenicity and protective efficacy of a bivalent inactivated
Wook-Jin Park et al.
Scientific reports, 11(1), 22037-22037 (2021-11-13)
Conjugate vaccine platform is a promising strategy to overcome the poor immunogenicity of bacterial polysaccharide antigens in infants and children. A carrier protein in conjugate vaccines works not only as an immune stimulator to polysaccharide, but also as an immunogen;
Active Filters
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico
